en · de · es · pt
lab-handbook.peptides6908.com › Wiki › Regulatory Status And Detection Context — Hands-On Walkthrough

Regulatory Status And Detection Context — Hands-On Walkthrough

By Editorial Desk · published 2026-05-14 · last reviewed 2026-06-01 · Wiki

This is a working overview of Prohibited substance, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-06-01 and is reviewed periodically as new material appears.

Regulatory Status and Detection Context

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Background and Regulatory History

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Cardarine at a glance

PropertyValueNotes
Regulatory statusNot approved for human therapeutic useNo marketing authorization identified in major jurisdictions.
Anti-doping classPPARδ agonist; hormone and metabolic modulatorsListed on the WADA Prohibited List.
Common test matrixUrineAlso blood and tissue in research settings.
Typical analytical methodLC-MS/MSTargets parent compound and metabolites.
Major safety signalTumor findings in rodentsHuman relevance not established; limited human data.

Identity and Pharmacological Mechanism

Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Related pages on this site

Background and Regulatory Status

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Further detail

=== Intracellular === Obligate intracellular parasites (e.g. Chlamydophila, Ehrlichia, Rickettsia) are only able to grow and replicate inside other cells. Infections due to obligate intracellular bacteria may be asymptomatic, requiring an incubation period. Examples of obligate intracellular bacteria include Rickettsia prowazekii (typhus) and Rickettsia rickettsii, (Rocky Mountain spotted fever). Chlamydia are intracellular parasites. These pathogens can cause pneumonia or urinary tract infection and may be involved in coronary heart disease. Other groups of intracellular bacterial pathogens include Salmonella, Neisseria, Brucella, Mycobacterium, Nocardia, Listeria, Francisella, Legionella, and Yersinia pestis. These can exist intracellularly, but can exist outside host cells.

A significant feature of the Cauchy equation and consequently all other continuum equations (including Euler and Navier–Stokes) is the presence of convective acceleration: the effect of acceleration of a flow with respect to space. While individual fluid particles indeed experience time-dependent acceleration, the convective acceleration of the flow field is a spatial effect, one example being fluid speeding up in a nozzle.

Hydrolysis and oxidation are the two primary degradation processes that occur in an oil during cooking. Oxidative stability is how resistant an oil is to reacting with oxygen, breaking down and potentially producing harmful compounds while exposed to continuous heat. Oxidative stability is the best predictor of how an oil behaves during cooking. The Rancimat method is one of the most common methods for testing oxidative stability in oils. This determination entails speeding up the oxidation process in the oil (under heat and forced air), which enables its stability to be evaluated by monitoring volatile substances associated with rancidity. It is measured as "induction time" and recorded as total hours before the oil breaks down. Canola oil requires 7.5 hours, for example, whereas extra virgin olive oil (EVOO) and virgin coconut oil will last over a day at 110 °C (230 °F) of continuous heat. The differing stabilities correlate with lower levels of polyunsaturated fatty acids, which are more prone to oxidation. EVOO is high in monounsaturated fatty acids and antioxidants, conferring stability. Some plant cultivars have been bred to produce "high-oleic" oils with more monounsaturated oleic acid and less polyunsaturated linoleic acid for enhanced stability. The oxidative stability does not directly correspond to the smoke point and thus the latter cannot be used as a reference for safe and healthy cooking.

Sources: en.wikipedia.org

Supporting material

== Recombinant protein design == The earliest applications of recombinant protein design can be documented in the use of single peptide tags for purification of proteins in affinity chromatography. Since then, a variety of fusion protein design techniques have been developed for applications as diverse as fluorescent protein tags to recombinant fusion protein drugs. Three commonly used design techniques include tandem fusion, domain insertion, and post-translational conjugation.

The downy woodpecker and hairy woodpecker look almost the same, as do some 'Chrysocolaptes and Dinopium flamebacks, the smoky-brown woodpecker and some Veniliornis species, and other Veniliornis species and certain "Picoides" and Piculus. In neither case are the similar species particularly close relatives. Many birds of Australia, like wrens and robins, look like Northern Hemisphere birds but are not related. Oilbirds like microbats and toothed whales developed sonar-like echolocation systems used for locating prey. The brain structure, forebrain, of hummingbirds, songbirds, and parrots responsible for vocal learning (not by instinct) is very similar. These types of birds are not closely related. Seriemas and secretary birds very closely resemble the ancient dromaeosaurid and troodontid dinosaurs. Both have evolved a retractable sickle-shaped claw on the second toe of each foot, both have feathers, and both are very similar in their overall physical appearance and lifestyle. Migrating birds like, Swainson's thrushes can have half the brain sleep with the other half awake. Dolphins, whales, Amazonian manatee and pinnipeds can do the same. Called unihemispheric slow-wave sleep. Brood parasitism, laying eggs in the nests of birds of other species, happens in types of birds that are not closely related. The charadriiform buttonquails closely resemble the galliform quails. Gallopheasants and junglefowl have similar tail-feathers but evolved them independently. Toucans and hornbills are very similar and occupy the same ecological niche, but are not closely related.

5 August – George Herd, 88, Scottish football player (Sunderland, national team) and manager (Queen of the South). 6 August – Ron Bain, 79, Scottish actor (Naked Video, A Kick Up the Eighties) and director (I, Lovett). (death announced on this date) Bobby Thomson, 87, Scottish footballer (Aston Villa, Birmingham City). 9 August – Brian Marjoribanks, 82, Scottish footballer (Hibernian), actor and broadcaster (BBC Scotland). 12 August – Alex Kinninmouth, 82, Scottish footballer (Dundee, Dunfermline Athletic, Forfar Athletic). (death announced on this date) 2 September – Mick Cullen, 93, Scottish footballer (Luton Town, Grimsby Town, national team). 3 September – Flora Fraser, 21st Lady Saltoun, 93, Scottish peer, member of the House of Lords (1979–2014). 6 September – Ron Yeats, 86, Scottish footballer (Dundee United, Liverpool, Tranmere Rovers). 17 September – Kenny Hyslop, 73, Scottish drummer (Slik, Zones, Simple Minds). (death announced on this date) 18 September – Sam Malcolmson, 77, Scottish-born New Zealand footballer (Queen of the South, Albion Rovers, national team). 10 October – Peter Cormack, 78, Scottish football player (Liverpool, national team) and manager (Partick Thistle). 12 October Jackmaster, 38, Scottish DJ and record producer. Alex Salmond, 69, politician, first minister (2007–2014). 13 October – Jim Liddle, 66, Scottish footballer (Forfar Athletic, Cowdenbeath, Hamilton Academical). 22 October – Jim McColl, 89, Scottish horticulturalist and television presenter (Beechgrove). Myra McFadyen, 68, Scottish actress (Made of Honor, Mamma Mia!, Emma).

On 23 January 2024, Tristan Thompson was suspended for 25 games by the NBA for testing positive for ibutamoren and LGD-4033. On 12 March 2024, curler Briane Harris was provisionally suspended for up to four years after testing positive for LGD-4033. She denies this after being tested by doping control officers on Jan. 24 and notified of her positive test on Feb. 15. A second sample, called the B sample, also confirmed the positive test. She appealed the ban to the Court of Arbitration for Sport (CAS), arguing she was unknowingly exposed to it through bodily contact. CAS ruled that "Harris has established that she bears No Fault or Negligence for the anti-doping rule violation. No period of Ineligibility is imposed."

Sources: en.wikipedia.org

Supporting material

==== Myosin storage myopathy ==== In myosin storage myopathies, myosin accumulates beneath sarcolemma and between myofibrils, forming protein aggregates. A myopathy associated with the gene MYH7 is autosomal dominant myosin storage congenital myopathy-7A (CMYP7A).

1993/2854) Birmingham City Council (Grand Union Canal Bridge) Scheme 1992 Confirmation Instrument 1993 (S.I. 1993/2855) Mid Essex Community and Mental Health National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2856) Wigan and Leigh Health Services National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2857) Public Airport Companies (Capital Finance) (Fourth Amendment) Order 1993 (S.I. 1993/2875) Conservation of Seals (England) Order 1993 (S.I. 1993/2876) Motor Vehicles Tyres (Safety) (Amendment) Regulations 1993 (S.I. 1993/2877) Local Government Reorganisation (Capital Money) (Greater London) (Amendment) Order 1993 (S.I. 1993/2878) Redbridge and Waltham Forest (London Borough Boundaries) Order 1993 (S.I. 1993/2881) Local Government (Compensation for Premature Retirement) (Amendment) Regulations 1993 (S.I. 1993/2890) Local Government Act 1988 (Defined Activities) (Exemption) (Wales) (No. 2) Order 1993 (S.I. 1993/2894) Protection of Wrecks (Designation No. 3) Order 1993 (S.I. 1993/2895) Community Health Sheffield National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2896) Public Telecommunication System Designation (Scottish Power Telecommunications Limited) Order 1993 (S.I. 1993/2897) Public Telecommunication System Designation (Torch Communications Limited) Order 1993 (S.I. 1993/2898) Public Telecommunication System Designation (MFS Communications Limited) Order 1993 (S.I. 1993/2899)

Blood coagulation: prothrombin (factor II), factors VII, IX, and X, and proteins C, S, and Z Bone metabolism: osteocalcin, matrix Gla protein (MGP), periostin, and Gla-rich protein. Vascular biology: Matrix Gla protein, growth arrest – specific protein 6 (Gas6) Unknown functions: proline-rich γ-carboxyglutamyl proteins 1 and 2, and transmembrane γ-carboxy glutamyl proteins 3 and 4.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine approved for any medical use?

No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.

Why is cardarine prohibited in sport?

It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.

What is known about cardarine and cancer?

Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Network